Unite Against Scleroderma 2012 PDF Print E-mail
Monday, 19 March 2012 21:13

For our second year running, the Scleroderma Care Foundation will be hosting its “Unite Against Scleroderma” Awareness Walk around the Queen’s Park Savannah, Port of Spain. Scheduled to start from 3:00pm, the Walk would be held on Sunday May 6th 2012 and cover one full lap.

The Walk ultimately aims to raise the profile of Scleroderma in the public consciousness - aligned with our ongoing mission to assist Scleroderma patients, their families, and respective communities through mutual social and financial support, educational initiatives, the stimulation of research, and bringing forth a greater awareness of Scleroderma.

We would also be aiming to highlight many of the challenges and needs of those who struggle to cope with Scleroderma daily, and that of the Foundation itself in seeking to secure wider support for its own initiatives and efforts to serve Scleroderma patients.

At the Walk’s end, all participants would be treated to light refreshments, a brief presentation from the Foundation’s President and co-founder Adelwyn Holder, other guest speakers, and performances by specially invited musical guests – all to be later announced.

As we are aware, Scleroderma is a rare, autoimmune, connective tissue disease characterized by the overproduction of collagen, which results in the thickening and hardening of the underlying connective tissues which support the skin, blood vessels, muscles, and internal organs such as the heart, lungs, and kidneys.

Scleroderma can limit a patient’s range of motion and ability to perform simple daily tasks due to fatigue, and the pain, swelling, and inflammation of the joints. With organ involvement, life can become particularly more challenging and life-threatening.

We would really like to encourage each of you to come out - bring your family, children, and friends - and walk with us on May 6th. T-shirts, Scleroderma silicone bands, and pins would also be on sale. All registered participants receive a participatory package inclusive of a branded event t-shirt.

Registration begins April 1st 2012, but you can download and fill out the registration forms from today. Registration costs for adults are $100 and children (under 12) $50. For more information, please do call us at 756-3930 or 685-3213 or email us This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

See below, some of the photos from last year’s Walk, and join us on Facebook to continue the discussion and get further updates, as we near the day :)


To view the rest of the photos, visit our gallery here.

 
More articles :

» Vitamin D Deficiency May Hasten Autoimmune Lung Disease

Patients with autoimmune interstitial lung disease (ILD) — a frequently fatal chronic inflammatory autoimmune disease that causes scarring of the lungs — often have deficiencies, and researchers from the University of Cincinnati believe this...

» Scleroderma in Children: Emerging Management Issues

Saumya PandaDepartment of Dermatology, KPC Medical College, Kolkata, IndiaDate of Web Publication: 21-Jul-2010Abstract         Scleroderma is a set of rare connective tissue diseases of unknown etiology. It is...

» PUVA Therapy In The Treatment of Localized Scleroderma

In localized , disease activity would tend to stop spontaneously over time. Treatment is important to reduce disabilities caused by the active phases of disease. According to , there are three treatments used in the treatment of localized...

» African Americans Have More Severe Complications From Scleroderma

African Americans have more severe complications from systemic sclerosis, also known as scleroderma, than Caucasians. Findings published today in, , a journal of the American College of Rheumatology (ACR), show that compared with Caucasians,...

» Placebo-controlled Study of Methotrexate in Juvenile Localised Scleroderma

According to the results of this placebo-controlled study, is an effective treatment for juvenile localised scleroderma (JLS). The authors note that JLS is a chronic progressive fibrotic process of the skin causing permanent disability and...

» Cancer Drug Shows Promise For Treating Scleroderma

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with , according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold...